Novartis not joining the 'frenzy' of weight loss drugs, CEO says

Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.

...

Op-ed: The financial toxicity of cancer is growing. Here's what can be done to reduce it

3 weeks ago

CVS replaces CEO Karen Lynch with exec David Joyner as profits, share price suffer

3 weeks ago

FDA eyes McDonald's supplier Taylor Farms as source of E. Coli outbreak

3 weeks ago

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

3 weeks ago

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity

2 weeks ago